Volume 89, Issue 5, Pages (May 2016)

Slides:



Advertisements
Similar presentations
Volume 66, Issue 6, Pages (December 2004)
Advertisements

Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 66, Issue 1, Pages (July 2004)
M.S. Mozaffari, C. Patel, R. Abdelsayed, S.W. Schaffer 
Volume 66, Issue 6, Pages (December 2004)
Volume 94, Issue 3, Pages (September 2018)
Volume 69, Issue 6, Pages (March 2006)
Volume 76, Issue 1, Pages (July 2009)
Volume 83, Issue 5, Pages (May 2013)
Sodium thiosulfate prevents vascular calcifications in uremic rats
Volume 58, Issue 4, Pages (October 2000)
Volume 91, Issue 2, Pages (February 2017)
Biomarkers in kidney fibrosis: are they useful?
Volume 61, Issue 4, Pages (April 2002)
Membranous nephropathy: When and how to treat
Critical role for osteopontin in diabetic nephropathy
Volume 68, Issue 5, Pages (November 2005)
Volume 88, Issue 2, Pages (August 2015)
Volume 67, Issue 1, Pages (January 2005)
Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors  H.-S. Huang, J. Chen, C.-F. Chen,
Volume 68, Issue 3, Pages (September 2005)
The intrarenal renin-angiotensin system in hypertension
Volume 63, Issue 3, Pages (March 2003)
Volume 59, Issue 5, Pages (May 2001)
Volume 92, Issue 1, Pages (July 2017)
Volume 56, Issue 4, Pages (October 1999)
Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension
Volume 76, Issue 3, Pages (August 2009)
Volume 63, Issue 2, Pages (February 2003)
Gene expression profiling in the remnant kidney model of wild type and kinin B1 and B2 receptor knockout mice  J.P. Schanstra, M. Bachvarova, E. Neau,
Volume 83, Issue 5, Pages (May 2013)
Volume 72, Issue 8, Pages (October 2007)
17-β Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters  S. Riazi, C. Maric, C.A. Ecelbarger 
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 92, Issue 3, Pages (September 2017)
Volume 64, Issue 1, Pages (July 2003)
Volume 56, Issue 4, Pages (October 1999)
Volume 60, Issue 4, Pages (October 2001)
Volume 85, Issue 3, Pages (March 2014)
Volume 66, Issue 1, Pages (July 2004)
Volume 68, Issue 2, Pages (August 2005)
Volume 70, Issue 11, Pages (December 2006)
Volume 66, Issue 4, Pages (October 2004)
Volume 71, Issue 9, Pages (May 2007)
Volume 73, Issue 7, Pages (April 2008)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 66, Issue 6, Pages (December 2004)
Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension  Zhenmin Ni, Shahrooz Bemanian, Salah D. Kivlighn,
Robert L. Chevalier, Barbara A. Thornhill, Alice Y. Chang 
Volume 81, Issue 8, Pages (April 2012)
Volume 78, Issue 5, Pages (September 2010)
Volume 63, Issue 6, Pages (June 2003)
Volume 68, Issue 4, Pages (October 2005)
Neurogenic factors and hypertension in renal disease
Volume 71, Issue 7, Pages (April 2007)
Volume 74, Issue 2, Pages (July 2008)
Volume 58, Issue 3, Pages (September 2000)
Karen A. Griffin, Anil K. Bidani  Kidney International 
Endothelin antagonists in renal disease
The course of the remnant kidney model in mice
Aldosterone in the development and progression of renal injury
Volume 80, Issue 10, Pages (November 2011)
A functional immature model of chronic partial ureteral obstruction1
Volume 61, Issue 1, Pages (January 2002)
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Friends, social networks, and progressive chronic kidney disease
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease  T.A.O. Jiang,
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Presentation transcript:

Volume 89, Issue 5, Pages 1049-1061 (May 2016) The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy  Oleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder, Karoline von Websky, Viktoriia Antonenko, Yuliya Sharkovska, Lyubov Chaykovska, Jan Rahnenführer, Ahmed A. Hasan, Harald Tammen, Markus Alter, Thomas Klein, Seiji Ueda, Sho-ichi Yamagishi, Seiya Okuda, Berthold Hocher  Kidney International  Volume 89, Issue 5, Pages 1049-1061 (May 2016) DOI: 10.1016/j.kint.2016.01.016 Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 1 UACR in study 1 and UPCR in study 2. (a) Urine albumin-to-creatinine ratio (UACR) in the core study (study 1) and (b) urine total protein-to-creatinine ratio (UPCR) in the confirmation study (study 2). Values are given as mean ± SEM. ∗∗∗P < 0.001 versus sham + placebo; #P < 0.05; ##P < 0.01; ###P < 0.001 versus 5/6 Nx + placebo. DPP-4, dipeptidyl peptidase-4; Nx, nephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 2 Kidney morphology. (a) Renal interstitial fibrosis, (b) typical photomicrographs of the kidneys stained with sirius red for interstitial fibrosis, (c) glomerular size, and (d) typical photomicrographs of the kidneys stained with sirius red for glomerular hypertrophy. Values are given as mean ± SEM. Bar = 100 μm. ∗∗P < 0.01 versus sham + placebo; #P < 0.05 versus 5/6 Nx + placebo. NS, not significant; Nx, nephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 3 Collagen type I and CD68 renal protein expression. Renal relative protein expression of (a) collagen type I and (b) cluster of differentiation 68 (CD68). Values are given as mean ± SEM. ∗P < 0.05 versus sham + placebo; #P < 0.05 versus 5/6 Nx + placebo. NS, not significant; Nx, nephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 4 Urinary DPP-4 activity and MDA urinary excretion. (a) Urinary dipeptidyl peptidase-4 (DPP-4) activity-to-creatinine ratio and (b) urinary malondialdehyde (MDA)-to-creatinine ratio. To control for variations in urinary flow rate, DPP-4 activity and MDA urinary excretion were normalized to creatinine. Values are given as mean ± SEM. ##P < 0.01 versus 5/6 Nx + placebo. NS, not significant; Nx, nephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 5 Plasma concentration of active incretins. (a) Plasma concentration of active glucagon-like peptide 1 (GLP-1) and (b) active glucose-dependent insulinotropic polypeptide (GIP). Values are given as mean ± SEM. ###P < 0.001 versus 5/6 Nx + placebo. Nx, nephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 6 Plasma parameters. Plasma concentration of (a) osteopontin, (b) calbindin, (c) beta-2 microglobulin (β2M), and (d) macrophage colony-stimulating factor 1 (M-CSF-1). Values are given as mean ± SEM. ∗∗P < 0.01; ∗∗∗P < 0.001 versus sham + placebo; #P < 0.05; ##P < 0.01 versus 5/6 Nx + placebo. NS, not significant; Nx, nephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 7 Results of univariate analyses of LC-MS data. The circles represent the total number of statistically significant different signals as well as up- and down-regulated signals in 5/6 Nx + telmisartan (TEL) and 5/6 Nx + linagliptin (LIN) groups in comparison to 5/6 Nx + placebo in (a) plasma and (b) kidney according to the results of univariate analysis of liquid chromatography and mass spectrometry (LC-MS) data. Arrows indicate the number of overlapping signals. Statistical thresholds: P < 0.01, area under the receiver-operating characteristics curve > 0.9, r > 0.6 (for plasma); P < 0.01, area under the receiver-operating characteristics curve > 0.95, r > 0.7 (for kidney). Nx, nephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 8 Identified peptides sorted by their mean signal-to-noise ratios. The bar plots depict the signal-to-noise ratios (SNRs) for identified peptides in (a) plasma and (b) kidney. Values are given as mean ± SEM. HNRNPA2B1, heterogeneous nuclear ribonucleoproteins A2/B1; Nx, nephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 9 Time course of the Core study (study 1). The experiment was started when the rats were 8 weeks old. MC, metabolic cages (to obtain 24-hour urine samples); OP1, uninephrectomy operation on the left side; OP2, amputation of the poles of right kidney; SBP, systolic blood pressure measurements; Uni-Nx, uninephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 10 Time course of the confirmation study (study 2). The study started when the rats were 8 weeks old. MC, metabolic cages (to obtain 24-hour urine samples); OP1, amputation of the poles of right kidney; OP2, uninephrectomy operation on the left side; SBP, systolic blood pressure measurements; Uni-Nx, uninephrectomy. Kidney International 2016 89, 1049-1061DOI: (10.1016/j.kint.2016.01.016) Copyright © 2016 International Society of Nephrology Terms and Conditions